WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry

Reuters10-28

WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry

WuXi AppTec Co. Ltd., a leading global pharmaceutical CRDMO, has announced the signing of two strategic memoranda of understanding (MoUs) with NEOM and the Ministry of Health $(MOH)$ of Saudi Arabia. The collaboration with NEOM aims to explore the localization of pharmaceutical research, development, and manufacturing in Saudi Arabia, including establishing world-class CRDMO facilities at Oxagon or other locations in the country. The MoU with the Ministry of Health will focus on localizing the pharmaceutical value chain, developing a large-scale pharmaceutical workforce, and attracting foreign direct investment. These partnerships are expected to drive innovation, accelerate the growth of the biotechnology sector in Saudi Arabia, and advance WuXi AppTec's mission to support global healthcare development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WuXi AppTec Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN08748) on October 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2578933722?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 17:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578933722","market":"nz","top_or_hot":-1,"title":"WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        WuXi AppTec Co. Ltd., a leading global pharmaceutical CRDMO, has announced the signing of two strategic memoranda of understanding (MoUs) with NEOM and the Ministry of Health <a href=\"https://laohu8.com/S/MOH\">$(MOH)$</a> of Saudi Arabia. The collaboration with NEOM aims to explore the localization of pharmaceutical research, development, and manufacturing in Saudi Arabia, including establishing world-class CRDMO facilities at Oxagon or other locations in the country. The MoU with the Ministry of Health will focus on localizing the pharmaceutical value chain, developing a large-scale pharmaceutical workforce, and attracting foreign direct investment. These partnerships are expected to drive innovation, accelerate the growth of the biotechnology sector in Saudi Arabia, and advance WuXi AppTec's mission to support global healthcare development.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WuXi AppTec Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN08748) on October 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-28 17:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        WuXi AppTec Co. Ltd., a leading global pharmaceutical CRDMO, has announced the signing of two strategic memoranda of understanding (MoUs) with NEOM and the Ministry of Health <a href=\"https://laohu8.com/S/MOH\">$(MOH)$</a> of Saudi Arabia. The collaboration with NEOM aims to explore the localization of pharmaceutical research, development, and manufacturing in Saudi Arabia, including establishing world-class CRDMO facilities at Oxagon or other locations in the country. The MoU with the Ministry of Health will focus on localizing the pharmaceutical value chain, developing a large-scale pharmaceutical workforce, and attracting foreign direct investment. These partnerships are expected to drive innovation, accelerate the growth of the biotechnology sector in Saudi Arabia, and advance WuXi AppTec's mission to support global healthcare development.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WuXi AppTec Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN08748) on October 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0456842615.SGD","symbol_name":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDLt2tbT:1","article_id":"2578933722","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578933722","pubTimestamp":1761642029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"WuXi AppTec Co. Ltd., a leading global pharmaceutical CRDMO, has announced the signing of two strategic memoranda of understanding  with NEOM and the Ministry of Health  of Saudi Arabia. The collaboration with NEOM aims to explore the localization of pharmaceutical research, development, and manufacturing in Saudi Arabia, including establishing world-class CRDMO facilities at Oxagon or other locations in the country. The MoU with the Ministry of Health will focus on localizing the pharmaceutical value chain, developing a large-scale pharmaceutical workforce, and attracting foreign direct investment. These partnerships are expected to drive innovation, accelerate the growth of the biotechnology sector in Saudi Arabia, and advance WuXi AppTec's mission to support global healthcare development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603259":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1997245177.USD":"安联神洲A股基金","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","BK0216":"研究试验","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD"},"translate_title":"药明康德与NEOM和沙特卫生部签署战略谅解备忘录，实现制药行业本地化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":0.9},"content_text":"WuXi AppTec Signs Strategic MoUs with NEOM and Saudi Ministry of Health to Localize Pharma Industry\n    \n\n        WuXi AppTec Co. Ltd., a leading global pharmaceutical CRDMO, has announced the signing of two strategic memoranda of understanding (MoUs) with NEOM and the Ministry of Health $(MOH)$ of Saudi Arabia. The collaboration with NEOM aims to explore the localization of pharmaceutical research, development, and manufacturing in Saudi Arabia, including establishing world-class CRDMO facilities at Oxagon or other locations in the country. The MoU with the Ministry of Health will focus on localizing the pharmaceutical value chain, developing a large-scale pharmaceutical workforce, and attracting foreign direct investment. These partnerships are expected to drive innovation, accelerate the growth of the biotechnology sector in Saudi Arabia, and advance WuXi AppTec's mission to support global healthcare development.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WuXi AppTec Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN08748) on October 28, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2578933722","isCrawlerRequest":true}